For a relatively small set of cases that involve patients who used Vioxx for over 18 months, we will take a close look.

We'll look at a relatively small subset of cases. But we have no intention of entering into a global settlement of any kind.

This is not a normal Vioxx case, which is about heart attacks and strokes being increased by the use of the drug, ... We plan on making it about the specifics of causation. ... This is a good case for us.

It is apparent that Toyobo was duped by Second Chance. We were shocked by the level of Second Chance's deception when their behavior was finally uncovered because of documents that surfaced in litigation and through investigation.

Cases we'll be looking at concern ingestion of Vioxx for 18 months or more by patients with limited heart risk factors.

We could decide to settle others. We are not entertaining the notion of a global settlement.

The new filings are not unexpected and do not change our strategy. Right now we are concentrating on defending each and every case we face.

The company has always said that every case presents a different set of facts. We will make a reasonable decision in how to proceed in defending each case.

We intend to try these cases one by one and that is exactly what we are doing.